Cargando…

Cardiovascular Manifestations of COVID-19

Coronavirus disease 2019 (COVID-19) first emerged in a group of patients who presented with severe pneumonia in Wuhan, China, in December 2019. A novel virus, now called SARS- CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), was isolated from lower respiratory tract samples. The current outb...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandy, Sneha, Wan, Siu-Hin, Brenes-Salazar, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762154/
https://www.ncbi.nlm.nih.gov/pubmed/33143614
http://dx.doi.org/10.2174/1573403X16999201102213827
_version_ 1784633695987040256
author Nandy, Sneha
Wan, Siu-Hin
Brenes-Salazar, Jorge
author_facet Nandy, Sneha
Wan, Siu-Hin
Brenes-Salazar, Jorge
author_sort Nandy, Sneha
collection PubMed
description Coronavirus disease 2019 (COVID-19) first emerged in a group of patients who presented with severe pneumonia in Wuhan, China, in December 2019. A novel virus, now called SARS- CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), was isolated from lower respiratory tract samples. The current outbreak of infection has spread to over 100 countries and killed more than 340,000 people as of 25(th) May, 2020. The predominant clinical manifestation of COVID-19 is a respiratory disease- ranging from mild flu-like symptoms to  fulminant  pneumonia and  Acute Respiratory Distress Syndrome  (ARDS). Patients with pre-existing cardiovascular risk factors are considered more susceptible to the virus, and these conditions are often worsened by the infection. Furthermore, COVID-19 infection has led to de novo cardiac complications, like acute myocardial injury and arrhythmias. In this review, we have focused on the cardiovascular manifestations of COVID-19 infection that have been reported in the literature so far. We have also outlined the effect of pre-existing cardiovascular disease as well as risk factors on the clinical course and outcomes of COVID-19 infection.
format Online
Article
Text
id pubmed-8762154
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-87621542022-07-20 Cardiovascular Manifestations of COVID-19 Nandy, Sneha Wan, Siu-Hin Brenes-Salazar, Jorge Curr Cardiol Rev Article Coronavirus disease 2019 (COVID-19) first emerged in a group of patients who presented with severe pneumonia in Wuhan, China, in December 2019. A novel virus, now called SARS- CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), was isolated from lower respiratory tract samples. The current outbreak of infection has spread to over 100 countries and killed more than 340,000 people as of 25(th) May, 2020. The predominant clinical manifestation of COVID-19 is a respiratory disease- ranging from mild flu-like symptoms to  fulminant  pneumonia and  Acute Respiratory Distress Syndrome  (ARDS). Patients with pre-existing cardiovascular risk factors are considered more susceptible to the virus, and these conditions are often worsened by the infection. Furthermore, COVID-19 infection has led to de novo cardiac complications, like acute myocardial injury and arrhythmias. In this review, we have focused on the cardiovascular manifestations of COVID-19 infection that have been reported in the literature so far. We have also outlined the effect of pre-existing cardiovascular disease as well as risk factors on the clinical course and outcomes of COVID-19 infection. Bentham Science Publishers 2021-07-20 2021-07-20 /pmc/articles/PMC8762154/ /pubmed/33143614 http://dx.doi.org/10.2174/1573403X16999201102213827 Text en © 2021 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Nandy, Sneha
Wan, Siu-Hin
Brenes-Salazar, Jorge
Cardiovascular Manifestations of COVID-19
title Cardiovascular Manifestations of COVID-19
title_full Cardiovascular Manifestations of COVID-19
title_fullStr Cardiovascular Manifestations of COVID-19
title_full_unstemmed Cardiovascular Manifestations of COVID-19
title_short Cardiovascular Manifestations of COVID-19
title_sort cardiovascular manifestations of covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762154/
https://www.ncbi.nlm.nih.gov/pubmed/33143614
http://dx.doi.org/10.2174/1573403X16999201102213827
work_keys_str_mv AT nandysneha cardiovascularmanifestationsofcovid19
AT wansiuhin cardiovascularmanifestationsofcovid19
AT brenessalazarjorge cardiovascularmanifestationsofcovid19